Drugs / OTC
OTC drug warning letters: CGMP themes to watch
Two May 2026 FDA warning letters point to common OTC manufacturing issues: validation, lab controls, and quality-unit oversight.
Short public-source articles built from FDA warning letters, recall entries, and category themes. Each piece is written for readers who want the source link before the opinion.
Drugs / OTC
Two May 2026 FDA warning letters point to common OTC manufacturing issues: validation, lab controls, and quality-unit oversight.
Devices
Class I recall entries show how software maintenance and BLE communication vulnerabilities can become public risk signals.
Food / imports
A practical scan of public Class I food recall entries from the latest digest sample.